mifepristone has been researched along with Leukemia in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, YH; Jang, JH; Kim, SH; Kwon, TK; Lee, TJ; Min, KJ; Park, EJ; Um, HJ; Woo, SM | 1 |
| Amadi, N; Check, JH; Chern, J; Katz, Y; Sansoucie, L | 1 |
| Check, JH; Srivastava, BI; Srivastava, MD; Thomas, A | 1 |
| Amadi, N; Check, JH; Chern, J; Larece, K; Sansoucie, L; Srivastava, M | 1 |
| Courtois, A; Drenou, B; Fardel, O; Fauchet, R; Lamy, T; le Prisé, PY; Lecureur, V | 1 |
| Harmon, JM; Ramdas, J | 1 |
| Schlechte, JA; Schmidt, TJ | 1 |
7 other study(ies) available for mifepristone and Leukemia
| Article | Year |
|---|---|
RU486, a glucocorticoid receptor antagonist, induces apoptosis in U937 human lymphoma cells through reduction in mitochondrial membrane potential and activation of p38 MAPK.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Colorectal Neoplasms; Cytochromes c; Enzyme Activation; Female; HCT116 Cells; Hormone Antagonists; Humans; Leukemia; Lung Neoplasms; Lymphoma; MAP Kinase Signaling System; Membrane Potential, Mitochondrial; Mifepristone; p38 Mitogen-Activated Protein Kinases; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Receptors, Glucocorticoid; U937 Cells | 2013 |
Mifepristone treatment improves length and quality of survival of mice with spontaneous leukemia.
Topics: Animals; Hormone Antagonists; Leukemia; Mice; Mice, Inbred AKR; Mifepristone; Olive Oil; Plant Oils; Receptors, Progesterone; Survival Rate; Time Factors | 2009 |
Expression and modulation of progesterone induced blocking factor (PIBF) and innate immune factors in human leukemia cell lines by progesterone and mifepristone.
Topics: alpha-Defensins; Antimicrobial Cationic Peptides; Cathelicidins; Gene Expression Regulation, Neoplastic; Hormone Antagonists; Humans; Interleukin-1 Receptor-Associated Kinases; Killer Cells, Natural; Leukemia; Mifepristone; Pregnancy Proteins; Progesterone; Progestins; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Suppressor Factors, Immunologic; Toll-Like Receptor 4; Tumor Cells, Cultured | 2007 |
Evidence that progesterone receptor antagonists may help in the treatment of a variety of cancers by locally suppressing natural killer cell activity.
Topics: Animals; Cell Line, Tumor; Hormone Antagonists; Humans; Killer Cells, Natural; Leukemia; Mice; Mifepristone; Pregnancy Proteins; Progesterone; Receptors, Progesterone; RNA, Messenger; Suppressor Factors, Immunologic | 2007 |
Inhibition of P-glycoprotein activity in human leukemic cells by mifepristone.
Topics: Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Doxorubicin; Drug Screening Assays, Antitumor; Hormone Antagonists; Humans; Leukemia; Mifepristone; Tumor Cells, Cultured | 1996 |
Glucocorticoid-induced apoptosis and regulation of NF-kappaB activity in human leukemic T cells.
Topics: Apoptosis; Chromatin; Dexamethasone; DNA Fragmentation; Drug Resistance; Glucocorticoids; Humans; Leukemia; Mifepristone; Mutation; NF-kappa B; Receptors, Glucocorticoid; T-Lymphocytes; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured | 1998 |
Use of [3H]cortivazol to characterize glucocorticoid receptors in a dexamethasone-resistant human leukemic cell line.
Topics: Cell Division; Cell Line; Cytosol; Dexamethasone; Drug Resistance; Enzyme Induction; Estrenes; Glutamate-Ammonia Ligase; Gonadal Steroid Hormones; Humans; Leukemia; Mifepristone; Neoplasm Proteins; Pregnatrienes; Receptors, Glucocorticoid; T-Lymphocytes | 1987 |